This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (104)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Neal A. Sher, MD; Richard A. Bowers, MD; Ralph W. Zabel, MD; Jonathan M. Frantz, MD; Richard A. Eiferman, MD; David C. Brown, MD; J. James Rowsey, MD; Paula Parker, COMT; Varda Chen, MD; Richard L. Lindstrom, MD

Arch Ophthalmol. 1991;109(4):491-498.

Abstract
• Phototherapeutic keratectomy using a 193-nm excimer laser was performed at four centers on 33 sighted patients with corneal opacity and/or irregular astigmatism. Pathologic conditions included anterior stromal and superficial scarring from postinfectious and posttraumatic causes, including inactive herpes simplex virus, anterior corneal dystrophies, recurrent erosions, granular dystrophy, and band keratopathy. Most patients received peribulbar anesthesia and underwent removal of the epithelium prior to laser ablation. A majority of patients had a reduction in the amount of corneal scarring and approximately half had improved visual acuity. No intraocular reaction or changes in endothelial counts were seen, and some patients avoided the need for penetrating keratoplasty. Reepithelialization usually occurred within 4 or 5 days and we noted no significant scarring secondary to use of the laser. It was difficult to eliminate preexisting irregular astigmatism despite the use of surface modulators, such as methylcellulose. A hyperopic shift secondary to corneal flattening was encountered in approximately 50% of the patients. A combination of myopic ablation, followed immediately by a secondary hyperopic steepening, may minimize this refractive change. The 193-nm excimer laser is an effective new tool in the treatment of selected patients with superficial corneal opacity from a variety of conditions.

Author Affiliations
From the Phillips Eye Institute, Metropolitan Mt Sinai Hospital, and the Department of Ophthalmology, University of Minnesota, Minneapolis (Drs Sher, Bowers, Zabel, Chen, and Lindstrom and Ms Parker); the Eye Center of Florida, Fort Myers (Drs Frantz and Brown); the Department of Ophthalmology, University of Louisville (Ky) and the Veterans Affairs Medical Center, Louisville (Dr Eiferman); and the Dean McGee Eye Institute, University of Oklahoma, Oklahoma City (Dr Rowsey).

Footnotes
Accepted for publication February 1, 1991.

Reprint requests to the Phillips Eye Institute, 2215 Park Ave, Minneapolis, MN 55404 (Dr Sher).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Corneal electrolysis for recurrence of corneal stromal dystrophy after keratoplasty
Mashima et al.
Br J Ophthalmol 2002;86:273-275.
ABSTRACT | FULL TEXT  

Effect of Topical Ascorbic Acid on Free Radical Tissue Damage and Inflammatory Cell Influx in the Cornea After Excimer Laser Corneal Surgery
Kasetsuwan et al.
Arch Ophthalmol 1999;117:649-652.
ABSTRACT | FULL TEXT  

Oxygen free radical damage in the cornea after excimer laser therapy
Hayashi et al.
Br J Ophthalmol 1997;81:141-144.
ABSTRACT | FULL TEXT  

Effect of Diclofenac, Ketorolac, and Fluorometholone on Arachidonic Acid Metabolites Following Excimer Laser Corneal Surgery
Phillips et al.
Arch Ophthalmol 1996;114:1495-1498.
ABSTRACT  

Central and Peripheral Endothelial Cell Changes After Excimer Laser Photorefractive Keratectomy for Myopia
Trocme et al.
Arch Ophthalmol 1996;114:925-928.
ABSTRACT  

One-Year Evaluation of Excimer Laser Photorefractive Keratectomy for Myopia and Myopic Astigmatism
Snibson et al.
Arch Ophthalmol 1995;113:994-1000.
ABSTRACT  

The Corneal Endothelium After Myopic Excimer Laser Photorefractive Keratectomy
Carones et al.
Arch Ophthalmol 1994;112:920-924.
ABSTRACT  

10 Years: Over 10 000 Manuscripts
Goldberg
Arch Ophthalmol 1994;112:749-751.
ABSTRACT  

Comparison of Excimer Laser Treatment of Astigmatism and Myopia
Taylor et al.
Arch Ophthalmol 1993;111:1621-1626.
ABSTRACT  

Arachidonic Acid Metabolites After Excimer Laser Corneal Surgery
Phillips et al.
Arch Ophthalmol 1993;111:1273-1278.
ABSTRACT  

Corneal Graft Rejection Episode After Excimer Laser Phototherapeutic Keratectomy
Hersh et al.
Arch Ophthalmol 1993;111:735-736.
ABSTRACT  

Excimer Laser Photorefractive Keratectomy in High Myopia: A Multicenter Study
Sher et al.
Arch Ophthalmol 1992;110:935-943.
ABSTRACT  

Unsuccessful Excimer Laser Phototherapeutic Keratectomy: Clinicopathologic Correlation
McDonnell et al.
Arch Ophthalmol 1992;110:977-979.
ABSTRACT  

The Use of the 193-nm Excimer Laser for Myopic Photorefractive Keratectomy in Sighted Eyes: A Multicenter Study
Sher et al.
Arch Ophthalmol 1991;109:1525-1530.
ABSTRACT  

The Altar of High Technology and the Excimer Laser
Olson
Arch Ophthalmol 1991;109:489-490.
ABSTRACT